journal article·2023-11-06

Flexible Synthesis Scheme and Application of AuNP Surface-Conjugatable Metaiodobenzylguanidine Derivatives for Enhanced Cellular Internalization

Natalie S. Potter, Alan McLean, Evan C. Bornowski, Thomas Hopkins, Jingyi Luo, John P. Wolfe, Wei Qian, Raoul Kopelman

ACS Materials Letters· Volume 5· Issue 11
Publisher page

Abstract

A synthesis of two metaiodobenzylguanidine (MIBG) derivatives is reported: N -[4-(guanidinomethyl)-2-iodophenyl]-3-mercaptopropanamide (MIBG-3-MPAM) and N -[4-(guanidinomethyl)phenyl]-3-mercaptopropanamide (BG-3-MPAM). The design of these molecules allows for their conjugation to a wide range of nanocarriers, such as pulsed-laser ablation (PLA)-synthesized gold nanoparticles (AuNPs), which are utilized here to assess uptake into neuroblastoma (NB), HeLa, and HEK cell lines. Through dark-field imaging and quantitative inductively coupled plasma mass spectrometry (qICP-MS), the MIBG derivatives are found to enhance total AuNP uptake in vitro by over 100× at sufficiently high molar ratios across cell lines, and the iodine atom is found to play an important role in further enhancing the uptake efficiency.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Laser-Ablation Synthesis of Nanoparticles · Diamond and Carbon-based Materials Research · Nonlinear Optical Materials Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

University of Michigan, Department of Chemistry, 930 N University Ave, Ann Arbor, Michigan 48109, United States

IMRA America, Inc., 1044 Woodridge Avenue, Ann Arbor, Michigan 48105, United States

Funding

National Cancer Institute

References (31)

Show source-provided references
1. 10.1067/mnc.2002.12147110.1067/mnc.2002.121471 ↗
2. 10.1148/rg.201615009910.1148/rg.2016150099 ↗
3. 10.1080/14737140.2017.128523010.1080/14737140.2017.1285230 ↗
4. 10.1002/pbc.2520010.1002/pbc.25200 ↗
5. 10.2967/jnumed.118.21746310.2967/jnumed.118.217463 ↗
6. 10.3390/cancers912017310.3390/cancers9120173 ↗
7. 10.1002/anie.20210196410.1002/anie.202101964 ↗
8. 10.2217/nnm.14.16910.2217/nnm.14.169 ↗
9. 10.1016/j.bbcan.2021.18853210.1016/j.bbcan.2021.188532 ↗
10. 10.1016/j.pdpdt.2021.10269710.1016/j.pdpdt.2021.102697 ↗
11. 10.1002/smll.20120310610.1002/smll.201203106 ↗
12. 10.1002/adhm.20190122310.1002/adhm.201901223 ↗
13. 10.4155/tde.13.810.4155/tde.13.8 ↗
14. 10.1039/C5TB00287G10.1039/C5TB00287G ↗
15. 10.1039/D1RA04054E10.1039/D1RA04054E ↗
16. 10.1021/acs.chemrev.6b0046810.1021/acs.chemrev.6b00468 ↗
17. 10.1016/j.cap.2017.08.00410.1016/j.cap.2017.08.004 ↗
18. 10.2147/IJN.S13783310.2147/IJN.S137833 ↗
19. 10.1002/advs.20160023710.1002/advs.201600237 ↗
20. 10.1021/acs.chemmater.1c0033610.1021/acs.chemmater.1c00336 ↗
21. 10.1038/s41467-020-20276-z10.1038/s41467-020-20276-z ↗
22. 10.3390/ijms2107248010.3390/ijms21072480 ↗
23. 10.1021/acs.accounts.9b0010310.1021/acs.accounts.9b00103 ↗
24. 10.1016/j.colsurfb.2014.06.00110.1016/j.colsurfb.2014.06.001 ↗
25. 10.1039/b712170a10.1039/b712170a ↗
26. 10.1021/acsnano.6b0014210.1021/acsnano.6b00142 ↗
27. 10.1111/j.1471-4159.2006.03717.x10.1111/j.1471-4159.2006.03717.x ↗
28. 10.1074/jbc.273.12.697610.1074/jbc.273.12.6976 ↗
29. 10.1016/j.bioactmat.2020.06.02410.1016/j.bioactmat.2020.06.024 ↗
30. 10.1021/acs.nanolett.7b0302110.1021/acs.nanolett.7b03021 ↗
31. 10.1002/ange.20190234710.1002/ange.201902347 ↗